Scholarlink

<p>Addictive drugs, notably opioid drugs, have significant societal implications, yet the cellular and molecular mechanisms underpinning rewarding effects remain largely elusive. Noncoding transcripts, including the microRNAs (miRNAs), are pivotal regulators of diverse biological functions. Notably, the microRNAs miR-132 and miR-212, arising from a shared noncoding transcript, have links to several psychiatric conditions, including cocaine addiction. However, their contribution to opiate rewarding remains speculative. In this study, we discovered that repeated morphine administration decreases the expression of miR-132/212 in the ventral tegmental area (VTA) and induces a concurrent upregulation of the dopamine transporter (DAT). Using a luciferase reporter assay, we found that the DAT coding gene, SLC6A3 mRNA 3’UTR, is a direct target of miR-132/212. These miRNAs negatively regulated both mRNA expression and protein levels of DAT in vitro. This was corroborated by in vivo studies which revealed that behavioral experiments using a morphine-induced conditioned place preference (CPP) paradigm showed that suppression of miR-132/212 in the VTA facilitated the formation of morphine-induced CPP. Conversely, overexpression of miR-132 attenuated morphine preference in male and female adult rats, as well as adolescents. In sum, our findings uncover a regulatory mechanism wherein miR-132/212 modulates morphine induced reward behavior by fine-tuning DAT expression at the posttranscriptional level, providing a potential therapeutic target of rewarding effects.</p><p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

MicroRNA-132/212 negatively modulates opioid reward by targeting dopamine transporter in the ventral tegmental area

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月25日

查看全文
  • Jie Meng,
  • Zhonghao Li,
  • Yi Zhang,
  • Dajun Zhang,
  • Haiting Liu,
  • Xiangyang Zang,
  • Yaqiong Zhao,
  • Jing Wen,
  • Wei Shu,
  • Xiaoke Nan,
  • Xianchan Li,
  • Yan-Xue Xue,
  • Xiaojian Jia

摘要

Addictive drugs, notably opioid drugs, have significant societal implications, yet the cellular and molecular mechanisms underpinning rewarding effects remain largely elusive. Noncoding transcripts, including the microRNAs (miRNAs), are pivotal regulators of diverse biological functions. Notably, the microRNAs miR-132 and miR-212, arising from a shared noncoding transcript, have links to several psychiatric conditions, including cocaine addiction. However, their contribution to opiate rewarding remains speculative. In this study, we discovered that repeated morphine administration decreases the expression of miR-132/212 in the ventral tegmental area (VTA) and induces a concurrent upregulation of the dopamine transporter (DAT). Using a luciferase reporter assay, we found that the DAT coding gene, SLC6A3 mRNA 3’UTR, is a direct target of miR-132/212. These miRNAs negatively regulated both mRNA expression and protein levels of DAT in vitro. This was corroborated by in vivo studies which revealed that behavioral experiments using a morphine-induced conditioned place preference (CPP) paradigm showed that suppression of miR-132/212 in the VTA facilitated the formation of morphine-induced CPP. Conversely, overexpression of miR-132 attenuated morphine preference in male and female adult rats, as well as adolescents. In sum, our findings uncover a regulatory mechanism wherein miR-132/212 modulates morphine induced reward behavior by fine-tuning DAT expression at the posttranscriptional level, providing a potential therapeutic target of rewarding effects.